Bookmark
Forward
New Indication for Weight Loss Drug Semaglutide.
The American journal of nursing 2023 Jun 01Sizes of these terms reflect their relevance to your search.
The weight loss drug semaglutide (Wegovy) is now approved for pediatric patients ages 12 and older whose body mass index categorizes them as obese. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Citation
Diane S Aschenbrenner. New Indication for Weight Loss Drug Semaglutide. The American journal of nursing. 2023 Jun 01;123(6):19
Mesh Tags
Substances
PMID: 37233137
View Full Text
